Rahimi Farid, Talebi Bezmin Abadi Amin
Research School of Biology, The Australian National University, Canberra, Australia.
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Arch Med Res. 2020 Apr;51(3):280-281. doi: 10.1016/j.arcmed.2020.03.005. Epub 2020 Mar 27.
The last month of 2019 harbingered the emergence of a viral outbreak that is now a major public threat globally. COVID-19 was first diagnosed and confirmed in a couple of cases with unknown pneumonia; the patients lived in, or travelled to, Wuhan, the capital of China's Hubei province. People now face a complex challenge that deserves urgent intervention by all involved in medical healthcare globally. Conventional antiviral therapies or vaccines are the most referred means of tackling the virus, but we think establishing these ideal management strategies is presently far-fetched. In-house isolation or quarantine of suspected cases to keep hospital admissions manageable and prevent in-hospital spread of the virus, and promoting general awareness about transmission routes are the practical strategies used to tackle the spread of COVID-19. Cases with weakened or compromised immune systems-for example, elderly individuals, young children, and those with pre-existing conditions such as diabetes, cancer, hypertension, and chronic respiratory diseases-are particularly more susceptible to COVID-19. Hopefully, cumulative data using whole-genome sequencing of the SARS-CoV-2 genome in parallel with mathematical modeling will help the molecular biologists to understand unknown features of the pathogenesis and epidemiology of COVID-19.
2019年的最后一个月预示着一场病毒爆发的出现,这场爆发如今已成为全球重大的公共威胁。新型冠状病毒肺炎(COVID-19)最初在几例不明原因肺炎病例中被诊断和确认;这些患者居住在中国湖北省省会武汉或曾前往武汉。如今,人们面临一项复杂的挑战,这值得全球所有医疗保健相关人员紧急干预。传统的抗病毒疗法或疫苗是应对该病毒最常提及的手段,但我们认为目前要确立这些理想的管理策略还遥不可及。对疑似病例进行居家隔离或检疫,以控制住院人数并防止病毒在医院内传播,以及提高对传播途径的普遍认识,是用于应对COVID-19传播的实际策略。免疫系统薄弱或受损的人群,例如老年人、儿童以及患有糖尿病、癌症、高血压和慢性呼吸道疾病等基础疾病的人,尤其更容易感染COVID-19。有望通过对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组进行全基因组测序并结合数学建模积累的数据,帮助分子生物学家了解COVID-19发病机制和流行病学的未知特征。